Published in Int J Clin Pract on April 01, 2006
A two cases clinical report of mandragora poisoning in primary care in Crete, Greece: two case report. Cases J (2009) 0.81
When natural is not harmless. Int J Clin Pract (2006) 0.75
Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J (2001) 5.29
Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet (1999) 5.27
Rational targeting of Notch signaling in cancer. Oncogene (2008) 3.02
Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation (1998) 2.75
Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-kappaB and PPARgamma. Cell Death Differ (2002) 2.60
Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther (2009) 2.41
The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology (1990) 2.32
Endoscopic demonstration of loss of duodenal folds in the diagnosis of celiac disease. N Engl J Med (1988) 2.27
Screening test for coeliac disease. Lancet (1997) 2.23
Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet (1998) 2.15
Detection of malabsorption of low doses of carbohydrate: accuracy of various breath H2 criteria. Gastroenterology (1993) 2.15
Onset of coeliac disease during treatment with interferon for chronic hepatitis C. Lancet (2000) 2.13
Randomised clinical trial: the efficacy and safety of propionyl-L-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment. Aliment Pharmacol Ther (2011) 2.12
Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients. Cancer (1995) 2.11
Atrophic gastritis as a cause of hyperhomocysteinaemia. Aliment Pharmacol Ther (2004) 2.09
Hydrogen peroxide-related colitis (previously known as "pseudolipomatosis"): a series of cases occurring in an epidemic pattern. Endoscopy (2007) 2.07
Atypical sarcoidosis: case reports and review of the literature. Eur Rev Med Pharmacol Sci (2009) 1.98
Oral desensitizing treatment in food allergy: clinical and immunological results. Aliment Pharmacol Ther (2003) 1.88
Notch-1 regulates NF-kappaB activity in hemopoietic progenitor cells. J Immunol (2001) 1.84
Current European concepts in the management of Helicobacter pylori infection--the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol (1997) 1.81
Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther (2005) 1.78
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther (2006) 1.76
Ultrasound imaging in diagnosis of superior mesenteric artery syndrome. J Intern Med (2005) 1.76
Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther (2002) 1.73
Notch-1 stimulates survival of lung adenocarcinoma cells during hypoxia by activating the IGF-1R pathway. Oncogene (2010) 1.70
Investigation of the Karnofsky Performance Status as a measure of quality of life. Health Psychol (1984) 1.69
ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor. Oncogene (2008) 1.69
Helicobacter pylori reinfection and rapid relapse of low-grade B-cell gastric lymphoma. Lancet (1995) 1.68
Body composition changes induced by chronic ethanol abuse: evaluation by dual energy X-ray absorptiometry. Am J Gastroenterol (2000) 1.63
Oral disodium cromoglycate treatment on irritable bowel syndrome: an open study on 101 subjects with diarrheic type. Am J Gastroenterol (1992) 1.62
Autoimmune enteropathy and villous atrophy in adults. Lancet (1997) 1.62
Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria. Dig Dis Sci (1998) 1.61
Prevalence and early diagnosis of coeliac disease in autoimmune thyroid disorders. Ital J Gastroenterol Hepatol (1999) 1.60
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial. Aliment Pharmacol Ther (2003) 1.59
Bone mass and metabolism in patients with celiac disease. Gastroenterology (1995) 1.59
Endoscopic markers in adult coeliac disease. Dig Liver Dis (2002) 1.58
Serological screening of coeliac disease: choosing the optimal procedure according to various prevalence values. Gut (1994) 1.57
Methodology of the H2 breath test. II. Importance of the test duration in the diagnosis of carbohydrate malabsorption. Ital J Gastroenterol (1990) 1.55
Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther (2005) 1.54
Howell-Jolly body counting as a measure of splenic function. A reassessment. Clin Lab Haematol (1990) 1.54
Anticardiolipin antibodies in giant cell arteritis and polymyalgia rheumatica: a study of 40 cases. Br J Rheumatol (1998) 1.54
The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther (2001) 1.52
Ultrasonography in the diagnosis of portal hypertension: diminished response of portal vessels to respiration. Radiology (1982) 1.52
Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status. Scand J Gastroenterol (1997) 1.52
Epithelial-cell apoptosis and proliferation in Helicobacter pylori-related chronic gastritis. Ital J Gastroenterol Hepatol (1998) 1.50
The duration of antigen receptor signalling determines CD4+ versus CD8+ T-cell lineage fate. Nature (2000) 1.49
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig Liver Dis (2010) 1.45
A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy. Hepatology (1989) 1.43
Treatment of primary sclerosing cholangitis with low-dose ursodeoxycholic acid: results of a retrospective Italian multicentre survey. Dig Liver Dis (2003) 1.42
Ageing affects anoxia/reoxygenation injury in rat hepatocytes. Scand J Gastroenterol (1998) 1.42
Clinical nutrition practice in Italian Gastroenterology Units. Dig Liver Dis (2001) 1.42
Interferon alpha plus ketoprofen or interferon alpha plus ribavirin in chronic hepatitis C non-responder to interferon alpha alone: results of a pilot study. Ital J Gastroenterol Hepatol (1999) 1.41
Uteroglobin/Clara cell 10-kDa family of proteins: nomenclature committee report. Ann N Y Acad Sci (2000) 1.41
Doppler ultrasound evaluation of acute effects of cigarette smoking on portal blood flow in man. J Gastroenterol Hepatol (1996) 1.40
Notch-1 associates with IKKalpha and regulates IKK activity in cervical cancer cells. Oncogene (2008) 1.40
Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa. Dig Liver Dis (2005) 1.39
Effect of a vegetable-protein-rich polymeric diet treatment on body composition and energy metabolism in inactive Crohn's disease. Eur J Gastroenterol Hepatol (2000) 1.39
Antithrombin III in patients with hepatocellular carcinoma. Thromb Haemost (1987) 1.39
Subclinical coeliac disease is a frequent cause of iron-deficiency anaemia. Scand J Gastroenterol (1995) 1.39
[Whipple's disease: progress in the diagnosis and review of the literature]. Minerva Med (2002) 1.38
Acquired gastric mucosa-associated lymphoid tissue (MALT): a review with special emphasis on association with extragastric diseases and management problems of gastric MALT. J Clin Gastroenterol (1999) 1.38
Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence. Alcohol Clin Exp Res (2000) 1.38
Notch-1 controls the expression of fatty acid-activated transcription factors and is required for adipogenesis. J Biol Chem (1997) 1.36
Bacteroides thetaiotaomicron in the gut: molecular aspects of their interaction. Dig Liver Dis (2007) 1.36
DR and non-DR Ia allotypes are associated with susceptibility to coeliac disease. Gut (1985) 1.35
Notch and the immune system. Immunity (1999) 1.33
Gastrointestinal amyloidosis: a case of chronic diarrhoea. Eur Rev Med Pharmacol Sci (2009) 1.31
Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. Diabetes (1999) 1.31
Quantitative assessment of the mucosal architecture of jejunal biopsy specimens: a comparison between linear measurement, stereology, and computer aided microscopy. J Clin Pathol (1985) 1.30
Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells. Oncogene (2009) 1.29
Anisakis infestation: a case of acute abdomen mimicking Crohn's disease and eosinophilic gastroenteritis. Dig Liver Dis (2005) 1.27
Insulin resistance directly correlates with increased saturated fatty acids in skeletal muscle triglycerides. Metabolism (2000) 1.27
Noninvasive antigen-based assay for assessing Helicobacter pylori eradication: a European multicenter study. The European Helicobacter pylori HpSA Study Group. Am J Gastroenterol (2000) 1.26
Prevalence and clinical presentation of subclinical/silent celiac disease in adults: an analysis on a 12-year observation. Hepatogastroenterology (2001) 1.25
Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection. Aliment Pharmacol Ther (2000) 1.24
Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence. Br J Cancer (2011) 1.23
State and trait anxiety and depression in patients affected by gastrointestinal diseases: psychometric evaluation of 1641 patients referred to an internal medicine outpatient setting. Int J Clin Pract (2008) 1.23
Phospholipase A2 enzymes: regulation and physiological role. Biochem Pharmacol (1994) 1.22
New developments about the association of SV40 with human mesothelioma. Oncogene (2003) 1.22
Subclinical celiac sprue. Increasing occurrence and clues to its diagnosis. J Clin Gastroenterol (1993) 1.20
Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries. J Virol (2001) 1.19
Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome. Aliment Pharmacol Ther (2005) 1.19
Liver transplantation: the Italian experience. Dig Liver Dis (2002) 1.19
Review article: breath testing for human liver function assessment. Aliment Pharmacol Ther (2002) 1.19
Gluten specific suppressor T cell dysfunction in coeliac disease. Gut (1986) 1.17
High dosage rifaximin for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther (2007) 1.17
Probiotic treatment increases salivary counts of lactobacilli: a double-blind, randomized, controlled study. Digestion (2004) 1.17
Cutaneous manifestations in celiac disease. World J Gastroenterol (2006) 1.16
A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther (2000) 1.16
Helicobacter pylori infection in patients affected by insulin-dependent diabetes mellitus. Eur J Gastroenterol Hepatol (1998) 1.16
Helicobacter pylori eradication helps resolve pyloric and duodenal stenosis. J Clin Gastroenterol (1996) 1.16
Oral cromolyn sodium in comparison with elimination diet in the irritable bowel syndrome, diarrheic type. Multicenter study of 428 patients. Scand J Gastroenterol (1995) 1.15
Fatty liver and drugs. Eur Rev Med Pharmacol Sci (2005) 1.15